DaiWai M. Olson

Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke

Jeffrey L. Saver, Gregg C. Fonarow, Eric E. Smith et al. · JAMA · 2013 · 848 citations

Cerebrovascular Disease, Cerebral Vascular Regulation, Thrombosis +19

Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke

Gregg C. Fonarow, Eric E. Smith, Jeffrey L. Saver et al. · Circulation · 2011 · 572 citations

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Sherry Chou, Ettore Beghi, Raimund Helbok et al. · JAMA Network Open · 2021 · 405 citations · Full text

Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke

Gregg C. Fonarow, Mathew J. Reeves, Eric E. Smith et al. · Circulation Cardiovascular Quality and Outcomes · 2010 · 338 citations

Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care

David Menon, Giuseppe Citerio, Paul Vespa et al. · Intensive Care Medicine · 2014 · 300 citations · Full text